Cytomegalovirus Reactivation in Patients with Multiple Myeloma Treated with Teclistamab: Risk Factors and Clinical Impact

被引：0
|
作者：
Pei, Charles [1 ]
Blackburn, Lisa [2 ]
Sharma, Nidhi [3 ]
Bumma, Naresh [4 ]
Khan, Abdullah Mohammad [5 ]
Devarakonda, Srinivas [6 ]
Umyarova, Elvira [7 ]
Benson, Don [8 ]
Rosko, Ashley [9 ]
El Boghdadly, Zeinab [10 ]
Cottini, Francesca [9 ]
机构：
[1] Ohio State Univ, Coll Med, Columbus, OH USA
[2] Ohio State Univ, Coll Med, Columbus, OH USA
[3] Ohio State Univ, Med Ctr, Div Hematol, Columbus, OH USA
[4] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH USA
[5] Ohio State Univ, Div Hematol, Columbus, OH USA
[6] Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH USA
[7] Ohio State Univ, Comprehens Canc Ctr, Dept Internal Med, Div Hematol, Columbus, OH USA
[8] Ohio State Univ, Med Ctr, Columbus, OH USA
[9] Ohio State Univ, Columbus, OH USA
[10] Ohio State Univ, Wexner Med Ctr, Dept Internal Med, Div Infect Dis, Columbus, OH USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-201519
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4717 / 4718
页数：2
相关论文
共 50 条
  • [21] RISK FACTORS FOR CYTOMEGALOVIRUS REACTIVATION IN PATIENTS WITH CONNECTIVE-TISSUE DISEASES
    Ota, Y.
    Kaneko, Y.
    Takeuchi, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 405 - 406
  • [22] Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality
    Gatto, Ilenia
    Biagioni, Emanuela
    Coloretti, Irene
    Farinelli, Carlotta
    Avoni, Camilla
    Caciagli, Valeria
    Busani, Stefano
    Sarti, Mario
    Pecorari, Monica
    Gennari, William
    Guaraldi, Giovanni
    Franceschini, Erica
    Meschiari, Marianna
    Mussini, Cristina
    Tonelli, Roberto
    Clini, Enrico
    Cossarizza, Andrea
    Girardis, Massimo
    INTENSIVE CARE MEDICINE, 2022, 48 (06) : 706 - 713
  • [23] Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality
    Ilenia Gatto
    Emanuela Biagioni
    Irene Coloretti
    Carlotta Farinelli
    Camilla Avoni
    Valeria Caciagli
    Stefano Busani
    Mario Sarti
    Monica Pecorari
    William Gennari
    Giovanni Guaraldi
    Erica Franceschini
    Marianna Meschiari
    Cristina Mussini
    Roberto Tonelli
    Enrico Clini
    Andrea Cossarizza
    Massimo Girardis
    Intensive Care Medicine, 2022, 48 : 706 - 713
  • [24] Dosing Patterns and Early Safety and Effectiveness Outcomes in Patients with Multiple Myeloma Treated with Teclistamab in the Community Setting
    Beer, Timothy C.
    Graf, Gloria H. J.
    Lin, Dee
    Fernandez, Mariana
    Doyle, Margaret
    Hester, Laura L.
    Wu, Bingcao
    Huo, Stephen
    BLOOD, 2024, 144 : 2398 - 2399
  • [25] Administration of teclistamab in four patients with multiple myeloma requiring hemodialysis
    Khouderchah, Christy J.
    Ochs, Madeleine
    Pianko, Matthew
    Mahmoudjafari, Zahra
    Snyder, Jordan
    Ahmed, Iman
    Campagnaro, Erica
    Nachar, Victoria R.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024, 30 (06) : 1089 - 1095
  • [26] Ambulatory teclistamab administration in patients with relapsed/refractory multiple myeloma
    Tabbara, Nadeem
    Singel, Michael
    Allen, Natalie
    Mooney, Kathy
    Shedeck, Audra
    Zukas, Amber
    Campion, Kate
    Sollenberger, Callan
    Gocke, Christian Burris
    Ali, Syed Abbas
    Huff, Carol Ann
    Imus, Philip H.
    Waheed, Sarah
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [27] Trial in Progress: A Retrospective Multi-Country Study of Clinical Outcomes in Patients with R/R Multiple Myeloma Treated with Teclistamab Outside of Clinical Trials
    Perrot, Aurore
    Harel, Stephanie
    Kortuem, K. Martin
    Uttervall, Katarina
    Kishore, Bhuvan
    Cavo, Michele
    Takchi, Rana
    Santra, Diptendu
    Albrecht, Claire
    Rubio-Azpeitia, Eva
    Popat, Rakesh
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S78 - S78
  • [28] Risk and impact of tuberculosis in patients with multiple myeloma
    Tsai, Chun-Kuang
    Huon, Leh-Kiong
    Ou, Shuo-Ming
    Kuan, Ai-Seon
    Yeh, Chiu-Mei
    Lee, Yu-Ting
    Liu, Yao-Chung
    Chen, Tzeng-Ji
    Liu, Jin-Hwang
    Liu, Chia-Jen
    LEUKEMIA & LYMPHOMA, 2017, 58 (11) : 2598 - 2606
  • [29] Risk Factors for Early Cytomegalovirus Reactivation and Impact of Early Cytomegalovirus Reactivation on Clinical Outcomes after T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide
    Mariotti, Jacopo
    Legrand, Faezeh
    Furst, Sabine
    Giordano, Laura
    Magri, Filippo
    Richiardi, Lorenzo
    Granata, Angela
    De Philippis, Chiara
    Maisano, Valerio
    Faraci, Danilo
    Sarina, Barbara
    Giaccone, Luisa
    Harbi, Samia
    Mannina, Daniele
    Valli, Viviana
    Tordato, Federica
    Mineri, Rossana
    Bramanti, Stefania
    Santoro, Armando
    Bruno, Benedetto
    Devillier, Raynier
    Blaise, Didier
    Castagna, Luca
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (03): : 169.e1 - 169.e9
  • [30] Risk Factors for Cytomegalovirus Reactivation in Patients with Antineutrophil Cytoplasmic Antibody -Associated Vasculitis
    Ota, Yuichiro
    Kaneko, Yuko
    Kurasawa, Takahiko
    Yamaoka, Kunihiro
    Suzuki, Katsuya
    Takeuchi, Tsutomu
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
12345